Comparison of alfuzosin and tamsulosin in patients suffering from acute urinary retention caused by benign prostatic hyperplasia (BPH) showed that Both groups had similar results which were significantly superior than placebo. Three months, followup suggested that alfuzosin- or tamsulosin-treated patients showed a significant decrease in AUA score and PVRV; and a significant increase in PFR as compared to placebo. Tamsulosin is considred to have comparable therapeutic benifits as that of alfuzosin in all respects, except a small but significant side effect of retrograde ejaculation. Detailed report available in Indian Journal of Urology (Indian J Urol)
2009 | October-December | Volume 25 | Issue 4.
Dr. Shivamurthy Nanjundappa, MD (Pharmacology)
Director - Clinical Research and Business Development
Quartesian Clinical Research Pvt Ltd
Official Email ID: shiva.murthy@quartesian.com
Mobile No: +919677632414
Fax: +91-80-41689771
Alternate Email ID: shivuindia@yahoo.com
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Thanks for your comment. please send your mail at shivuindia@yahoo.com if you have some urgent message.